BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mortezaee K. Human hepatocellular carcinoma: Protection by melatonin. J Cell Physiol 2018;233:6486-508. [DOI: 10.1002/jcp.26586] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Lan M, Zhang Y, Wan X, Pan M, Xu Y, Sun S. Melatonin ameliorates ochratoxin A-induced oxidative stress and apoptosis in porcine oocytes. Environmental Pollution 2020;256:113374. [DOI: 10.1016/j.envpol.2019.113374] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
2 Najafi M, Farhood B, Mortezaee K. Contribution of regulatory T cells to cancer: A review. J Cell Physiol 2019;234:7983-93. [PMID: 30317612 DOI: 10.1002/jcp.27553] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 16.8] [Reference Citation Analysis]
3 Mortezaee K, Najafi M. Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives. Crit Rev Oncol Hematol 2021;157:103180. [PMID: 33264717 DOI: 10.1016/j.critrevonc.2020.103180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
4 Li Z, He J, Li B, Zhang J, He K, Duan X, Huang R, Wu Z, Xiang G. Titanium dioxide nanoparticles induce endoplasmic reticulum stress-mediated apoptotic cell death in liver cancer cells. J Int Med Res 2020;48:300060520903652. [PMID: 32281441 DOI: 10.1177/0300060520903652] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zhou B, Yang C, Yan X, Shi Z, Xiao H, Wei X, Jiang N, Wu Z. LETM1 Knockdown Promotes Autophagy and Apoptosis Through AMP-Activated Protein Kinase Phosphorylation-Mediated Beclin-1/Bcl-2 Complex Dissociation in Hepatocellular Carcinoma. Front Oncol 2020;10:606790. [PMID: 33552978 DOI: 10.3389/fonc.2020.606790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Farhood B, Najafi M, Mortezaee K. CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review. J Cell Physiol. 2019;234:8509-8521. [PMID: 30520029 DOI: 10.1002/jcp.27782] [Cited by in Crossref: 258] [Cited by in F6Publishing: 262] [Article Influence: 64.5] [Reference Citation Analysis]
7 Pu J, Wang J, Qin Z, Wang A, Zhang Y, Wu X, Wu Y, Li W, Xu Z, Lu Y, Tang Q, Wei H. IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism. Front Oncol 2020;10:578816. [PMID: 33224879 DOI: 10.3389/fonc.2020.578816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Najafi M, Farhood B, Mortezaee K. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J Cell Biochem. 2019;120:2782-2790. [PMID: 30321449 DOI: 10.1002/jcb.27681] [Cited by in Crossref: 82] [Cited by in F6Publishing: 95] [Article Influence: 20.5] [Reference Citation Analysis]
9 Zhang L, He Y, Wu X, Zhao G, Zhang K, Yang CS, Reiter RJ, Zhang J. Melatonin and (-)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer. Cells 2019;8:E745. [PMID: 31331008 DOI: 10.3390/cells8070745] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Jianghong L, Tingting M, Yingping Z, Tong Y, Lanxia Z, Jingwen L, Wentao Z, Pengbo C, Hong Y, Fuqiang H. Aptamer and Peptide-Modified Lipid-Based Drug Delivery Systems in Application of Combined Sequential Therapy of Hepatocellular Carcinoma. ACS Biomater Sci Eng 2021;7:2558-68. [PMID: 34047187 DOI: 10.1021/acsbiomaterials.1c00357] [Reference Citation Analysis]
11 Li X, Wang J. Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis. Int J Biol Sci 2020;16:2014-28. [PMID: 32549750 DOI: 10.7150/ijbs.44943] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
12 Majidpoor J, Mortezaee K. Steps in metastasis: an updated review. Med Oncol 2021;38:3. [PMID: 33394200 DOI: 10.1007/s12032-020-01447-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
13 Najafi M, Goradel NH, Farhood B, Salehi E, Solhjoo S, Toolee H, Kharazinejad E, Mortezaee K. Tumor microenvironment: Interactions and therapy. J Cell Physiol. 2019;234:5700-5721. [PMID: 30378106 DOI: 10.1002/jcp.27425] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 17.8] [Reference Citation Analysis]
14 Hashemi Goradel N, Najafi M, Salehi E, Farhood B, Mortezaee K. Cyclooxygenase-2 in cancer: A review. J Cell Physiol 2019;234:5683-99. [PMID: 30341914 DOI: 10.1002/jcp.27411] [Cited by in Crossref: 178] [Cited by in F6Publishing: 169] [Article Influence: 44.5] [Reference Citation Analysis]
15 Li JJ, Liang Q, Sun GC. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. J Integr Med 2021;19:469-77. [PMID: 34538644 DOI: 10.1016/j.joim.2021.08.004] [Reference Citation Analysis]
16 Farhood B, Najafi M, Mortezaee K. Cancer‐associated fibroblasts: Secretions, interactions, and therapy. J Cell Biochem 2019;120:2791-800. [DOI: 10.1002/jcb.27703] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
17 Farhood B, Najafi M, Salehi E, Hashemi Goradel N, Nashtaei MS, Khanlarkhani N, Mortezaee K. Disruption of the redox balance with either oxidative or anti-oxidative overloading as a promising target for cancer therapy. J Cell Biochem 2019;120:71-6. [PMID: 30203529 DOI: 10.1002/jcb.27594] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
18 Sheng J, Sun H, Yu FB, Li B, Zhang Y, Zhu YT. The Role of Cyclooxygenase-2 in Colorectal Cancer. Int J Med Sci 2020;17:1095-101. [PMID: 32410839 DOI: 10.7150/ijms.44439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
19 Zhang Y, Tighe S, Zhu YT. COX-2 Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2020;1277:87-104. [PMID: 33119867 DOI: 10.1007/978-3-030-50224-9_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Najafi M, Salehi E, Farhood B, Nashtaei MS, Hashemi Goradel N, Khanlarkhani N, Namjoo Z, Mortezaee K. Adjuvant chemotherapy with melatonin for targeting human cancers: A review. J Cell Physiol 2019;234:2356-72. [PMID: 30192001 DOI: 10.1002/jcp.27259] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
21 Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy. J Cell Physiol 2019;234:12173-87. [PMID: 30537043 DOI: 10.1002/jcp.27955] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
22 Najafi M, Hashemi Goradel N, Farhood B, Salehi E, Nashtaei MS, Khanlarkhani N, Khezri Z, Majidpoor J, Abouzaripour M, Habibi M, Kashani IR, Mortezaee K. Macrophage polarity in cancer: A review. J Cell Biochem 2019;120:2756-65. [DOI: 10.1002/jcb.27646] [Cited by in Crossref: 112] [Cited by in F6Publishing: 115] [Article Influence: 28.0] [Reference Citation Analysis]
23 Wang J, Lu L, Luo Z, Li W, Lu Y, Tang Q, Pu J. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway. Biomedicine & Pharmacotherapy 2019;120:109551. [DOI: 10.1016/j.biopha.2019.109551] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
24 Zhao YJ, Xie L. Potential role of exosomes in cancer therapy. Prec Radiat Oncol 2019. [DOI: 10.1002/pro6.66] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Wu J, Bai Y, Wang Y, Ma J. Melatonin and regulation of autophagy: Mechanisms and therapeutic implications. Pharmacol Res 2021;163:105279. [PMID: 33161138 DOI: 10.1016/j.phrs.2020.105279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R. Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers (Basel) 2021;13:6062. [PMID: 34885171 DOI: 10.3390/cancers13236062] [Reference Citation Analysis]
27 Baiocchi L, Zhou T, Liangpunsakul S, Ilaria L, Milana M, Meng F, Kennedy L, Kusumanchi P, Yang Z, Ceci L, Glaser S, Francis H, Alpini G. Possible application of melatonin treatment in human diseases of the biliary tract. Am J Physiol Gastrointest Liver Physiol 2019;317:G651-60. [PMID: 31509434 DOI: 10.1152/ajpgi.00110.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
28 Rong B, Feng R, Liu C, Wu Q, Sun C. Reduced delivery of epididymal adipocyte‐derived exosomal resistin is essential for melatonin ameliorating hepatic steatosis in mice. J Pineal Res 2019;66:e12561. [DOI: 10.1111/jpi.12561] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
29 Mortezaee K. Redox tolerance and metabolic reprogramming in solid tumors. Cell Biol Int 2021;45:273-86. [PMID: 33236822 DOI: 10.1002/cbin.11506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
30 Mortezaee K. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review. Cell Biochem Funct 2018;36:292-302. [PMID: 30028028 DOI: 10.1002/cbf.3351] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
31 Mortezaee K, Majidpoor J. CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives. Front Immunol 2022;13:864298. [DOI: 10.3389/fimmu.2022.864298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Renn T, Yang C, Wu U, Chen L, Mai F, Tikhonova MA, Amstislavskaya TG, Liao W, Lin C, Liu Y, Chang H. Water composed of reduced hydrogen bonds activated by localized surface plasmon resonance effectively enhances anti-viral and anti-oxidative activities of melatonin. Chemical Engineering Journal 2022;427:131626. [DOI: 10.1016/j.cej.2021.131626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol 2019;234:8381-95. [DOI: 10.1002/jcp.27740] [Cited by in Crossref: 117] [Cited by in F6Publishing: 118] [Article Influence: 29.3] [Reference Citation Analysis]
34 Turkez H, Tozlu OO, Arslan ME, Mardinoglu A. Safety and Efficacy Assessments to Take Antioxidants in Glioblastoma Therapy: From In Vitro Experiences to Animal and Clinical Studies. Neurochem Int 2021;150:105168. [PMID: 34450218 DOI: 10.1016/j.neuint.2021.105168] [Reference Citation Analysis]
35 Lorente L, Rodriguez ST, Sanz P, Abreu-González P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA. Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver Transplantation. Int J Mol Sci 2019;20:E1696. [PMID: 30959735 DOI: 10.3390/ijms20071696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Liu B, Zhao N, Zhou Y, Lu Y, Chen W, Huang Z, Wang D, Xu Y, Wai Ping Yam J, Cui Y. Circular RNA circ_ABCB10 in cancer. Clin Chim Acta 2021;518:93-100. [PMID: 33746018 DOI: 10.1016/j.cca.2021.03.010] [Reference Citation Analysis]
37 Bantounou M, Plascevic J, Galley HF. Melatonin and Related Compounds: Antioxidant and Inflammatory Actions. Antioxidants 2022;11:532. [DOI: 10.3390/antiox11030532] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Namjoo Z, Mortezaee K, Joghataei MT, Moradi F, Piryaei A, Abbasi Y, Hosseini A, Majidpoor J. Targeting axonal degeneration and demyelination using combination administration of 17β‐estradiol and Schwann cells in the rat model of spinal cord injury. J Cell Biochem 2018;119:10195-203. [DOI: 10.1002/jcb.27361] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
39 Pourhanifeh MH, Mehrzadi S, Hosseinzadeh A. Melatonin and regulation of miRNAs: novel targeted therapy for cancerous and noncancerous disease. Epigenomics 2021;13:65-81. [PMID: 33350862 DOI: 10.2217/epi-2020-0241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 Zahedi T, Hosseinzadeh Colagar A, Mahmoodzadeh H. PTGS2 Over-Expression: A Colorectal Carcinoma Initiator not an Invasive Factor. Rep Biochem Mol Biol 2021;9:442-51. [PMID: 33969138 DOI: 10.52547/rbmb.9.4.442] [Reference Citation Analysis]
41 Gong J, Yan S, Yu H, Zhang W, Zhang D. Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma. Med Sci Monit 2018;24:7586-94. [PMID: 30353907 DOI: 10.12659/MSM.910844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
42 Abdollahzade N, Majidinia M, Babri S. Melatonin: a pleiotropic hormone as a novel potent therapeutic candidate in arsenic toxicity. Mol Biol Rep 2021;48:6603-18. [PMID: 34453671 DOI: 10.1007/s11033-021-06669-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]